Ahmedabad Municipal Corporation approves 17 tall buildings over 70 meters, generating ₹250 crore revenue. Western areas see massive development with 38 buildings exceeding 100 meters height across city.
SMS Pharmaceuticals shares surged 17% after USFDA approved reformulated Ranitidine tablets. The approval marks the drug's return to US market after 5 years, boosting company's growth prospects.
Lupin stocks trade at 21.7x P/E despite record earnings and 80 new products pipeline. Discover why this pharma giant might be undervalued and poised for next growth cycle with biosimilars and complex generics.
Madhya Pradesh Cabinet chaired by CM Dr Mohan Yadav approves multiple decisions including housing schemes, welfare measures, and administrative approvals. Key focus on public welfare and development.
Supreme Court Justice Ujjal Bhuyan delivers sharp dissent against retrospective environmental clearances, calling them 'anathema' to environmental law. Read the full analysis.
Supreme Court recalls verdict barring post-facto environmental clearances through 2:1 majority decision. Chief Justice Gavai leads bench reviewing Vanshakti judgment. Read full analysis.
Granules Life Sciences receives USFDA approval for new Hyderabad facility to manufacture diabetes drug Metformin HCL. Capacity: 10 billion tablets annually. Read more about this pharmaceutical milestone.
Karnataka Chief Minister Siddaramaiah issues stern warning to officials causing investment delays, demands faster clearances to match other states' efficiency.
RBL Bank's strategic shift from private to listed foreign bank status gains momentum as Emirates NBD anticipates regulatory approvals within 5-6 months, marking a significant evolution in India's banking landscape.